Search results for "learning"

Article Cytiva expanding US operations
Cytiva, a global life sciences leader, is investing in additional resins manufacturing operations outside of Sweden, for the first time in the company’s history, with the acquisition of a …

Article Challenges of scaling up buffer production for GMP and how to evaluate different solutions
This virtual workshop presents different options for scaling up buffer production. You will learn at what scale does it make sense to outsource your buffer production or invest in a hardw…

Article mRNA: the messenger
Exploring the mRNA manufacturing universe? Proceed with confidence with some top tips from our scientists on mRNA synthesis and production. Watch the video to learn more about keeping the environ…

Webcast Find the Right Intensification Strategy for Your Upstream and Downstream Processes
How do you know if an intensification approach will give you advantages over your current biomanufacturing process, and how do you choose the right one? Learn more from our process intensification exp…

Article Need solutions for large-scale production of mRNA-based molecules?
Therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. mRNA therapeutics offer precise and individualized therapy and avoid manufacturing issues associated wit…

Article Tools and methodologies for smarter downstream process development
Scibetta Smart process development is a collection of approaches to improve process outcomes and speed up process development. In this video, John Scibetta, Advanced Chromatogra…

Article Webcast: How to study membrane protein interactions
Learn how Anna Moberg studies activity and function of extracted membrane proteins.  WATCH NOW >>

Article e-Learning: what is quality by design (QbD)?
Key learnings: - Fundamentals of the QbD concept - How QbD fits within process development and process characterization - Key aspects of QbD, such as the principle of design space and est…

Article Advanced therapeutics process development using mechanistic modeling
Guterstam Watch the interview of Peter Guterstam and Nick Whitelock (Cytiva), and learn about the biological background of advanced therapeutics what mechanistic modelling …

Article Get to know: mAb variants - eLearning
Key learnings are: - Structure and binding domains for antibody variants - Advantages and disadvantages of different antibody fragments - Design strategies for bispecific antibodies (bsAbs) …

Previous PageNext Page